Breaking News on Contract Research, Manufacturing & Clinical Trials

Top Headlines

Update - facility expansion to continue

Therapure postpones IPO citing market conditions

Therapure Biopharma has postponed its IPO citing market conditions.

Piramal to invest $10m to add ADC capacity at Coldstream lab

Piramal has announced its intention to invest $10m (€8.9m) in Coldstream Laboratories, the US sterile injectable CDMO it bought last year.

Selvita to open new lab in Poland

Discovery services firm Selvita plans a new laboratory in Poland citing a desired to develop the facility as its “second heart.”

Envigo confirms susceptibility of rat models to HSV-2 infection

CRO Envigo has confirmed that two of its rat strains can catch the virus that causes genital herpes.

VC Renaissance: Index Ventures spin off Medicxi launches GSK and J&J backed €210m fund

Biologics developers backed by Medicxi Ventures’ new €210m ($229m) fund will use Lonza for contract manufacturing under an existing deal with Index Ventures .

Key Industry Events


Access all events listing

Our events, Shows & Conferences...